Related Experiment Video
Updated: Sep 27, 2025

07:34
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
2.8K
Intestinal Microbiome Inhibits CD8+ T Cells via the Calcineurin-NFAT Axis
Cancer Discovery
|April 8, 2022
Abstract:
Bacterial sensing activates the calcineurin-NFAT axis, inhibiting CD8+ T cells in colon cancer.
Insights
Bacterial sensing triggers the calcineurin-nuclear factor of activated T-cells (NFAT) pathway, which suppresses CD8+ T cell activity in colon cancer. This discovery offers new insights into immune evasion in colorectal tumors.
Area of Science:
- Immunology
- Microbiology
- Oncology
Background:
- CD8+ T cells are crucial for anti-tumor immunity in colorectal cancer.
- The tumor microenvironment in colon cancer often harbors bacteria that can influence immune responses.
- Understanding immune checkpoints and bacterial interactions is vital for developing novel cancer therapies.
Purpose of the Study:
- To investigate the role of bacterial sensing in modulating CD8+ T cell function within the colon cancer microenvironment.
- To elucidate the specific molecular pathways, including the calcineurin-NFAT axis, involved in this immune suppression.
Main Methods:
- Utilized mouse models of colon cancer with specific bacterial colonization.
- Employed techniques such as flow cytometry, immunohistochemistry, and molecular assays to analyze T cell activation and signaling pathways.
- Investigated the impact of inhibiting the calcineurin-NFAT axis on anti-tumor immunity.
Main Results:
- Demonstrated that bacterial sensing in colon cancer activates the calcineurin-NFAT signaling pathway.
- Showed that this activation leads to the inhibition of CD8+ T cell effector functions, impairing anti-tumor responses.
- Found that blocking the calcineurin-NFAT axis partially restored CD8+ T cell activity against colon tumors.
Conclusions:
- Bacterial sensing represents a significant mechanism for immune evasion in colon cancer by suppressing CD8+ T cells via the calcineurin-NFAT pathway.
- Targeting the calcineurin-NFAT axis could be a potential therapeutic strategy to enhance anti-tumor immunity in colorectal cancer.

